Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program

John B Carlin, Kristine K Macartney, Katherine J Lee, Helen E Quinn, James Peter Buttery, Ruth Lopert, Julie E Bines, Peter McIntyre

Research output: Contribution to journalArticleResearchpeer-review

141 Citations (Scopus)


Estimates of the risk of intussusception (IS) associated with currently licensed rotavirus vaccines (RV1 [Rotarix; GSK] and RV5 [RotaTeq; Merck] diverge. Contemporaneous introduction of both vaccines in Australia enabled a population-based assessment of risk.
Original languageEnglish
Pages (from-to)1427 - 1434
Number of pages8
JournalClinical Infectious Diseases
Issue number10
Publication statusPublished - 2013

Cite this